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ABSTRACT: Alteration of macrophage polarization from
inﬂammatory (M1) to anti-inﬂammatory (M2) phenotype can
have striking implications for the regeneration of injured
tissues, treatment of inﬂammatory diseases, and relief of
autoimmune disorders. Although certain cytokines like
interleukin (IL)-4 and IL-13 are capable of inducing M2
macrophage polarization, their therapeutic potential in vivo is
suﬀering from low eﬃcacy due to their instability and poor
access to target cells. Here, we report the synthesis of IL-4-
loaded hyaluronic acid (HA) particle for the targeted delivery
of cytokines through the high aﬃnity of HA to CD44
receptors of macrophages. HA carriers composed of low,
middle, and high molecular weight (MW) polymers were
synthesized using divinyl sulfone (DVS) cross-linking. The MW of HA had a negligible eﬀect on the physicochemical properties
and biocompatibility of the macrophages, but as an indicative of M2 polarization, a signiﬁcant change in the arginase-1 (Arg-1)
activity, TNF-α release, and IL-10 secretion was observed for the HA particles prepared with high MW polymers. Therefore,
these particles were loaded with IL-4 for simultaneous macrophage targeting and M1 to M2 reprogramming, evidenced by a
remarkable increase in the Arg-1 to iNOS ratio, as well as CD163 and CD206 upregulation in the M1 macrophages, which were
initially triggered by lipopolysaccharide and interferon-γ.
1. INTRODUCTION
Autoimmune disorders (ADs) are categorized as chronic
diseases derived from an imbalance between stimulatory and
regulatory mechanisms of the immune system, strongly
aﬀected by the genetic predisposition and environmental
condition.1−4 The trigger of immune pathways and systemic
inﬂammatory responses in AD may result in the damage of
healthy tissues by over-reacted immune cells. Many of the
proposed immunoregulatory approaches against ADs are
developed based on the blockage of the interaction between
antigen-presenting cells and T cells.5−8 Owing to the antigenic
complexity of ADs and the need to simultaneously target
multiple autoreactive T-cell speciﬁcities, traditional antigen-
speciﬁc approaches have been shifting toward new inves-
tigation for more advanced and eﬀective therapy of ADs
through the restoration of homeostasis in the immune function
and tissue repair by macrophage reprogramming into
immunoregulatory phenotypes.9−11
Macrophages are present in almost all the organs of adult
mammals and contribute signiﬁcantly to balanced immunity
and tissue homeostasis, recognized as a key capability to treat
autoimmune diseases through their polarization switching from
activated inﬂammatory M1 phenotype to M2 tissue regenerat-
ing macrophages. The polarization of macrophages can be
stimulated by diﬀerent noninﬂammatory biomolecules, such as
interleukin (IL)-4, IL-10, and IL-13.12−15 M1 macrophages are
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mostly overexpressed in ADs, and their suppression through
these cytokines can reduce the inﬂammatory reactions within
the body. For example, there has been intensive research on
the therapeutic eﬀects of IL-4 on various inﬂammatory disease
models. Nevertheless, there are big challenges associated with
the rapid degradation and diminished bioactivity of unpro-
tected IL-4 in the blood circulation, as well as poor targeting to
the cells of interest.16,17 Therefore, an eﬃcient delivery system
is required to protect and speciﬁcally target anti-inﬂammatory
cytokines (e.g., IL-4) to the eﬀector cells with the aim of
blocking pathogenic inﬂammation without impairing immunity
against infections and tumors, resulting in the expansion of
their clinical applications.
Kim et al. suggested that extralarge pores mesoporous silica
nanoparticles (XL-MSNs) possess high clinical potential for
modulating immune systems through high loading and delivery
of IL-4 as an M2-polarizing cytokine in vitro and in vivo. IL-4-
loaded XL-MSNs signiﬁcantly induced polarization of M2
macrophage in comparison to soluble IL-4.10,18 However, it is
presumable that by speciﬁc targeting of the IL-4 to the
macrophages, better M2 polarization responses can be
observed. For this purpose, CD44 targeting polymers, such
as hyaluronic acid (HA), can be applied since the macrophages
are recognized for the high expression of this protein on their
surface.19−22
HA is an anionic biologically active linear polymer with a
variety of molecular weights (MWs). It is biocompatible, can
be found in the extracellular matrix, and is responsible for
important biological functions, including cell interactions and
movements, cell proliferation, cell diﬀerentiation, etc.23,24 HA
has emerged as an ideal and versatile drug delivery vehicle due
to its water solubility, biodegradability, nontoxic nature, facile
chemical functionalization, and capability to be used as carriers
for diﬀerent payloads.25−27 Conﬁrmed by previous studies,28
the MW-dependent eﬀect of HA on macrophage polarization is
attributed to the induction of diﬀerent stimulatory or
suppressive signaling pathways after HA interaction with
macrophages through surface receptors, such as CD44,
hyaluronan-mediated motility receptor, Toll-like receptor 2
(TLR2), Toll-like receptor 4 (TLR4), and scavenger receptor
Stabilin-2 (STAB2).19,29 These receptors, particularly CD44,
have been introduced as the best candidate for HA-mediated
targeting of various cell types, including macrophages, by
which the circulation time of small particles can be extended
and the polarization process can be induced.30,31 As an
example, plasmid-DNA-encapsulated HA-poly(ethyleneimine)
nanoparticles were designed with the average size of 186 nm to
modulate macrophage reprogramming.32
As far as we know, there is no report demonstrating the
capability of pure HA particles to encapsulate immunoregu-
latory cytokines for macrophage reprogramming. Therefore,
we contemplated the design of such carriers to concurrently
protect and deliver IL-4 biomolecules to the macrophages. The
suggested platform can be used for combined targeting and
polarization of macrophages toward M2 phenotype. The
developed IL-4-loaded carrier is composed of HA polymer
Figure 1. Schematic illustration of the synthesis procedure for HA particles containing IL-4 within the dioctyl sulfosuccinate sodium salt (AOT)
reverse micelles. HA polymer solution containing IL-4 was added into the isooctane containing AOT and 1-heptanol (1-HP), forming inverse
emulsion droplets through the coverage of the HA and IL-4 within the amphiphilic AOT chains. Next, DVS addition resulted in the covalent
binding of HA chains and the formation of interpenetrating networks, which are able to retain the IL-4 intact for further targeting to macrophages
through the high tendency of HA toward CD44 surface ligands.
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assembled through the formation of water-in-oil inverse
microemulsion droplet and divinyl sulfone (DVS)-mediated
covalent cross-linking. The process of carrier synthesis is
schematically summarized in Figure 1. The physicochemical
characterization, biocompatibility, and cellular eﬀect of HA
particles made of low, medium, and high MW of the polymer
were assessed. The one with the highest M2 polarization
capability was then chosen for the loading of IL-4 and
immunity modulation via targeted delivery of the IL-4 cytokine
to obtain synergistic M2-polarizing eﬀect of the HA polymer
and the drug on the macrophages.
2. RESULTS AND DISCUSSION
2.1. Physicochemical Characterization of HA Par-
ticles. HA is a very important natural polymer, existing in
diﬀerent cells and tissues of the human body with key
biological functions in cell signaling and proliferation,
organization of the extracellular matrix, joint lubrication, and
wound healing.20,24,33−35 Owing to its biocompatibility and
biodegradation, great attention toward drug delivery, bio-
targeting, and tissue-engineering features of this polymer has
been given in recent years.24,25,30,31,33,36,37 Since the MW-
dependent biological impacts of HA polymer have been
previously proved,28 in the current study, we aimed to ﬁgure
out the eﬀect of HA particles, prepared with varied MWs of the
polymer, on the macrophages and then select the best one for
further investigation of IL-4 loading and synergistic M2
polarization.
Spherical-shaped particles were produced by means of
various MWs of HA within the reverse micelles of AOT.
Figure 2a demonstrates that the average size of the particles
instantly increased from ∼900 nm to 1.2 μm as a function of
MW increment (LMW, MMW, and HMW are representative
of the HA particles prepared by low, middle, and high MW
polymers, respectively). This observation can be associated
with the longer polymer chains of the polymer with higher
Figure 2. Physicochemical characterization of the HA particles prepared by HA polymers with diﬀerent MWs. LMW, MMW, and HMW represent
the particles prepared with low, middle, and high MW HA, respectively. (a) Size and ζ-potential of the HA particles. (b) Fourier transform infrared
(FTIR) spectra of HA particles, indicating bands at 1602 cm−1 for −COOH groups of the HA and at 1030 cm−1 for S−O and C−S stretching
frequencies of DVS. (c) Thermogravimetric analysis (TGA) of the HA particles. (d) Size−pH correlation of the HA particles. (e) ζ-Potential of the
particles at diﬀerent pH conditions in a 0.01 M KCl solution. The pH was adjusted using 0.1 M NaOH and 0.1 M HCl. (f−h) Scanning electron
microscopy (SEM) images of the HA particles prepared by low (f), middle (g), and high (h) MW of the HA polymer. Scale bars are 2 μm.
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MW, which produced bigger DVS-mediated chemically cross-
linked networks.
The surface charges of all types of particles were also
measured. The negative surface of the particles prepared with
HMW polymer was signiﬁcantly higher than the particles
prepared with LMW polymer (Figure 2a). It is plausible that
the higher number of carboxyl groups on HA polymer with a
longer chain resulted in a clear shifting of the ζ-potential of the
prepared particles toward lower negative values.
Next, attenuated total reﬂectance-Fourier transform infrared
(ATR-FTIR) spectra of HA particles were taken to
demonstrate successful formation of the particles through the
cross-linking of the HA and DVS. In all types of the prepared
particles, distinctive bands at 1602 cm−1 were observable for
−COOH functional groups of the disaccharide units in HA,
and the bands at 1030 cm−1 appeared for S−O and C−S
stretching frequencies of DVS (Figure 2b).
Thermal behavior of the HA particles showed no remarkable
eﬀect of the MW on the TG thermograms that were taken by
10 °C/min heating rate (Figure 2c). In general, two distinct
degradation temperatures were observed for HA particles. The
ﬁrst step of degradation started at 210−230 °C depending on
the MW of the polymer. In this step, 50−60% of the total
weight was lost before reaching 300 °C. When the temperature
reached 650 °C, the second degradation pattern started and
continued up to 850 °C in which the remained weights of all
types of the particles were less than 15%.
To investigate the stability of the HA particles in diﬀerent
pH values (ranging from 3 to 11), the changes in particle size
and ζ-potential of HA particles were measured with dynamic
light scattering (DLS) and their corresponding graphs are
shown in Figure 2d. The HA particles did not show any
signiﬁcant change in their size with pH alteration from 3 to 11.
Despite the presence of carboxyl groups, the particles did not
swell in basic pH conditions due to their compact and
nonporous nature achieved by high chemical cross-linking with
DVS. In contrast, the surface ζ-potential of all HA particles
changed from ca. +5 to −30 mV by increasing the pH from 2
to 10 (Figure 2e). The positive surface charge of the HA
particles at pH 2 is related to the high rate of protonation on
hydroxyl groups of the particles.
The SEM images of the HA particles (Figure 2f−h) showed
spherical morphology, which demonstrates no impact of the
polymer MW on the shape of the ﬁnal product. In addition, the
Figure 3. (a) Biocompatibility of the particles prepared with low, middle, and high MWs of the HA polymer. The eﬀect of HA’s MW on cell
viabilities of PBMC, KG-1, and J774A.1 cells after treatment with the particles at 37 °C for 24 and 48 h. The experiments were performed for
diﬀerent HA concentrations in a range of 25−600 μg/mL. (b) Hemocompatibility of the HA-based particles during the screening period of 24 h.
The tested concentrations include 100, 200, and 400 μg/mL of HA particles. LMW, MMW, and HMW are representative of the HA particles
prepared by low, middle, and high molecular weight polymers, respectively.
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observation is in line with the data achieved from DLS
measurement, showing the majority of the particles with the
size of around 1 μm. However, bigger particles could also be
observed in all samples, varying in the range of 1−5 μm.
2.2. In Vitro Biocompatibility. To assess the in vitro
safety and high cytocompatibility of diﬀerent HA particles
fabricated by various MWs of the polymer, a cell viability assay
was performed on diﬀerent cell lines, including peripheral
blood mononuclear cells (PBMC), KG-1 macrophages, and
J774A.1 macrophages after treatment with the carriers at a
concentration range of 25−600 μg/mL for 24 and 48 h at 37
°C. As shown in Figure 3a, all tested concentrations showed
high cytocompatibility on all three cell lines tested. The
viability of the cells slightly reduced by increasing the
incubation time and the concentration of the particles.
However, all values remained desirably above 80% in all time
points of various concentrations. Previous studies have shown
the distinct eﬀect of the MW on cellular function of the cells
treated with HA.28,38 HMW HA was able to suppress cell cycle
via binding to CD44, whereas cell proliferation was stimulated
by LMW HA when interacted with CD44.22,37,39,40 However,
in our study, we just observed 20% variation in the viability of
the cells exposed to particles prepared with diﬀerent MWs of
HA polymer (Figure 3a). In another study, researchers have
shown the promotion of cell proliferation after treatment with
HMW HA.21 These diﬀerences and controversies might be
attributed to the cell type, variation of the polymer MW in
diﬀerent studies, and the form of HA (e.g., polymer solution,
Figure 4. Impact of MW of the HA particles on Arg-1 expression, TNF-α suppression, and the induction of IL-10 secretion in the (a) resting, (b)
LPS-triggered, and (c) classically activated J774A.1 macrophages. The schematics demonstrate the time course of the experiments. LMW and
MMW HA particles had minimal eliciting eﬀect on M2 polarization since very slight changes in the expressions of Arg-1 and IL-10 release were
observed. In contrast, HMW HA particles could more remarkably reduce the level of TNF-α in all three tested conditions and could also increase
the Arg-1 and IL-10 levels. Error bars represent mean ± standard deviation (SD) of three independent experiments.
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nanoparticles, microparticles, or as a coating layer for other
nanomaterials) used for the studies. All these factors can aﬀect
the regulation of signaling pathways through the change in the
internalization of the polymer into the cells.25 Overall, these
results showed acceptable in vitro safety and biocompatibility
of HA-based particles, which can be therefore used as carriers
for drug delivery applications.
2.3. Hemocompatibility. Red blood cells (RBCs) are the
most abundant cells in the bloodstream and in very close
contact with the particulate drug delivery systems after
intravenous injection. Therefore, there is a risk of deformation
and cell membrane damage if the particles are toxic.41,42 To
investigate the eﬀect of the HA’s MW on the lysis of RBCs,
HA-based particles, in a concentration range of 100−400 μg/
mL, were exposed to the hemoglobins. When treated for 1 and
6 h, the RBC lysis was much less than the longer exposure time
(24 h) in all the HA-based particles tested (Figure 3b),
demonstrating the dependency of the hemolysis rate to the
exposure time. Whereas 100 μg/mL of all the HA-based
carriers induced less than 4% hemolysis after 24 h, 400 μg/mL
of the particles could meaningfully enhance the rate of
hemolysis to more than 9%, especially in cells treated by
MMW HA-based particles. This indicates concentration and
MW dependency in hemolysis eﬀect of HA particles.
Overall, our data represented a direct relationship of
concentration, MW, and exposure time with the hemolysis
rate of the RBCs. The induction of hemolysis was higher for
MMW and HMW HA-based particles as compared to the
LMW HA-based counterparts; however, it was less than 10% in
all cases. The high hemocompatibility of the HA particles can
be explained through the hydrophilicity and negative surface
charge of the particles that prevent their interaction and
penetration into the RBCs due to surface negative charges and
hydrophobic lipid bilayer of the plasma membrane. The
comparison of MWs showed that LMW HA-based particles
caused lower hemolysis rate presumably due to the relatively
weaker interaction with the cell surface. It can be due to
varying structural conformations of HAs with various MWs in
solution, resulting from diﬀerences in ﬂexibility and viscosity of
HA chains.27
2.4. Impact of HA Particles on Resting and Activated
Macrophages. Depending on their cellular phenotype and
cytokine secretion pattern, macrophages are able to either
mediate or suppress inﬂammatory responses. Programmed
switching of macrophages from an inﬂammatory (M1) to anti-
inﬂammatory (M2) phenotype renders substantial beneﬁt for
the treatment of inﬂammatory and autoimmune diseases, as
well as the regeneration of injured tissues. It was previously
shown that the MWs of polymers have the capability of
eliciting diﬀerent biological responses.20,25 In this regard,
before IL-4 loading into the HA particles, the role of MW on
the reprogramming of macrophages was investigated. To
provide a synergistic eﬀect for IL-4 payloads, we were looking
for a polymer with M2-polarizing eﬀect as a carrier for this
cytokine. Therefore, the impact of particles prepared by low,
middle, and high MWs of the HA polymer was investigated on
the arginase-1 (Arg-1) expression, TNF-α release, and IL-10
production in resting macrophages, lipopolysaccharide (LPS)-
stimulated macrophages, and LPS + IFN-γ costimulated
macrophages (Figure 4).
For the resting macrophages shown in Figure 4a, Arg-1
expression was signiﬁcantly upregulated after treatment with
particles made of HMW HA, whereas treatment with LMW
and MMW HA particles demonstrated lower population of the
Arg-1 positive cells. Arg-1 expression on cell surface is a
signature of M2 macrophage polarization.10,43 TNF-α
production in macrophages treated by HMW HA particles
was also lower than other types of particles and the nontreated
cells. Although this test was performed with the HA particles,
the ﬁnding was in line with previous reports that showed the
ability of the HMW HA polymer in solution form for the
suppression of TNF-α production, known as an indicator of
anti-inﬂammatory response for the M2 polarization of the
macrophages.28 This ﬁnding shows the potential of the
developed particles with HMW HA polymer to develop
drug-loaded carriers for AD therapy through M2 macrophage
activity.
Next, the secretion of IL-10 was examined, and it
demonstrated a signiﬁcant upregulation in resting macrophages
treated with HMW polymer compared to the other conditions
examined. IL-10 is an anti-inﬂammatory cytokine generally
produced by M2 macrophages, and the upregulation of IL-10
proves the successful transition from M1 to M2 phenotype via
HA treatment. As expected, particles prepared by HMA HA
could downregulate the production of M1 cytokines, such as
TNF-α, but upregulate IL-10 secretion as a known M2
cytokine.27 This ﬁnding suggests that not only the polymeric
solution of HA, but also the particulate form of HMA HA can
elicit M2 state from resting macrophages.
In the next step, HA and LPS were simultaneously exposed
to the resting macrophages to mimic an acute classical
inﬂammatory response against LPS, an antigen derived from
Gram-negative bacterial wall. According to previous reports,
LPS is able to mediate acute inﬂammation as a potent
macrophage activator and to produce many inﬂammatory
mediators, such as TNF-α and IL-6.36,44 It is revealed in Figure
4b that the highest Arg-1 expression was acquired in
macrophages treated with HMW HA particles, and other
types showed no signiﬁcant diﬀerences compared to the
control. It is also shown that TNF-α secretion tended to
increase in the presence of LPS that exempliﬁes the high
sensitivity of macrophages to the inﬂammatory challenge with
LPS. Cotreatment with LPS and HA particles resulted in
contrary eﬀect with decreasing TNF-α level in an MW-
dependent manner. As it is clear in Figure 4b, macrophages
treated with HMW HA particles decreased TNF-α secretion in
a magnitude of six compared to the LPS-treated macrophages.
In the case of IL-10, the highest secretion level was observed
following treatment with HMW HA particles by which the
activation of macrophages toward M2 phenotype is strongly
feasible, whereas LPS alone and particles prepared by low and
middle MW of HA did not have any capability to increase the
secretion level of IL-10.
Next, the impacts of HA particles on classically activated
macrophages were investigated in the presence of both IFN-γ
and LPS. There are many chronic diseases associated with
classically activated state of macrophages as it can have huge
detrimental eﬀects on various tissues.45−48 Therefore, we tried
to mimic the classically activated macrophages through
pretreatment with both IFN-γ and LPS to represent a robust
inﬂammatory response before exposure to HA particles.
Development of a particulate system, which can alter the
population of such macrophages, would have a remarkable role
in the alteration of macrophage function within damaged
tissue. As shown in Figure 4c, it is obviously clear that the
greatest increase in Arg-1 expression was observed in
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macrophages treated with HMW HA, which was signiﬁcantly
higher than those of LMW and MMW HA particles.
Compared to LPS-treated macrophages, TNF-α production
was increased fourfold more in the presence of LPS + INF-γ,
demonstrating the potential of INF-γ for macrophage
activation in certain chronic inﬂammatory conditions.36 In
this experiment, macrophages were classically activated for 24
h, and then, the media were replaced with media containing
HA particles. After 24 h of the treatment with HA particles
with various MWs, increased Arg-1 expression and IL-10
secretion, as well as reduced level of TNF-α production was
observed for HMW particles. In all cases, an MW-dependent
trend was observed. In general, these data prove that treatment
with HMW HA particles elicits signals needed for the M2
polarization of macrophages.
2.5. Cellular Targeting and M1 to M2 Repolarization.
The main prerequisite for the targeting of macrophages by HA
particles is the high availability of CD44 receptor on the
surface of the cell membrane. Therefore, the expression of
CD44 was evaluated on J774A.1 macrophages by confocal
microscopy and ﬂow cytometry instruments. Figure 5a,b shows
the strong ﬂuorescence of the cell membrane stained with
FITC-CD44 antibody and a clear shift in the histogram of
J774A.1, respectively. The indicated high expression of CD44
on the cell membrane conﬁrms the potential of HA particles to
target these cells. Time-dependent eﬃcient in vitro cellular
uptake (Figure 5c), which occurred by the HMW particles of
HA, could possibly conﬁrm CD44 receptor recognition by the
particles and subsequent promotion in their interaction with
the cell membrane and enhanced endocytosis.49 In the
polymeric backbone of the HA, the C6-OH of N-acetylglucos-
amine (GlcNAC) forms hydrogen bonding to CD44 on the
macrophages. HA is a polymer with repetitive units of the
GlcNAC and another ring functionalized with −COOH and
−OH. Considering the low amount of the DVS and observed
data of eﬃcient CD44 targeting, it seems there are many of the
free C6-OH of GlcNAC groups in the structure of HA for
CD44 targeting after conjugation with DVS, conﬁrmed by the
FTIR bond at 3500 cm−1, corresponding to −OH groups of
the HA particles (Figure 2).
The internalization of the IL-4-loaded particles would then
increase the expression and production of M2-polarizing genes,
proteins, and biomolecules, as shown in Figure 5d−f, and the
switching of M1 polarized macrophages toward M2 phenotype.
In this experiment, J774A.1 macrophages were ﬁrst treated
with LPS and IFN-γ for 16 h to increase the expression of M1
markers.32 Next, the stimulated cells were treated with the IL-
4-loaded HA particles, and the expressions of M2 markers were
determined. The yield of the particle formation was ca. 90%,
and the calculated amount of IL-4 in 100 μg of HA particles
was 51.4 ± 2.8 ng (equal to a loading eﬃciency of ca. 92.5%).
The M1 macrophages present high expression levels of
CD80, TNF-α, and iNOS, whereas the M2a polarization of
macrophages is associated with a decrease in M1 markers and
an increase in Arg-1, CD163, and CD206 levels. Therefore, to
investigate if IL-4-loaded HA particles could repolarize the
macrophages from M1 to M2a phenotypes, Arg-1/iNOS (Arg-
1/iNOS) ratio was measured by qPCR in the M1 phenotype
cells treated with the particles for 24 and 48 h (Figure 5d).
According to previous reports,50 the M2 polarization of
macrophages is associated with a decreased expression of
iNOS and an increase in Arg-1 level. Therefore, the ratio of
Arg-1 to iNOS can be an indication of macrophage
polarization to M2 phenotype. As shown in Figure 5d, the
Figure 5. Analysis of CD44 expression in J774A.1 macrophages using (a) confocal microscopy and (b) ﬂow cytometry. (c) Cellular uptake of the
HMW particles of HA in J774A.1 macrophages. The uptake of the particles into the cells increased over time. (d) Change in the ratio of Arg-1 to
iNOS after 24 and 48 h of treatment with IL-4-loaded (HMW-IL-4) and unloaded (HMA) HA particles. This is indicative of the M2/M1 ratio of
the macrophages, which were initially triggered by LPS and IFN-γ toward the M1 phenotype. (e, f) Flow cytometry histograms of the CD206 and
CD163 expressions in LPS- and IFN-γ-stimulated J774A.1 macrophages without and with exposure to IL-4-loaded (HMW-IL-4) and unloaded
(HMA) HA particles for 48 h at the concentration of 100 μg/mL (1.2 mL).
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Arg-1/iNOS ratio was remarkably low in the M1 macrophages,
indicating the high expression of iNOS and low expression of
Arg-1. In contrast, this ratio was dramatically increased after
treatment with both unloaded and IL-4-loaded particles for 24
and 48 h. The Arg-1/iNOS ratio was higher in the IL-4-loaded
particles compared to the unloaded counterparts at both time
points, demonstrating the eﬀect of IL-4 on the enhanced M2
repolarization of the macrophages. Furthermore, the observed
time-dependent increase in the Arg-1/iNOS ratio can
presumably be attributed to the sustained release of IL-4
within the cells after internalization.
As speciﬁc surface markers for M2a macrophages,51 the
change in the expressions of CD206 and CD163 was evaluated
in the J774A.1 macrophages. Figure 5e,f show the histograms
of CD206 and CD163 expressions in M1 J774A.1 macro-
phages exposed to the unloaded and IL-4-loaded particles for
48 h. The LPS- and IFN-γ-treated M1 macrophages were
considered as control. The shift to the higher ﬂuorescence
intensity values was observed for both CD206 and CD163
proteins after treatment with the unloaded and loaded
particles, indicating the upregulation of M2 surface markers.
The shifting of the histogram was higher for the IL-4-loaded
HA particles compared to the unloaded one. This result
suggests that the loading of IL-4 plays a signiﬁcant role in the
eﬃcient M2 polarization of the cells after the cellular uptake of
the particles.
In general, the developed HA carriers could induce
immunoregulatory responses against autoimmunity and
inﬂammatory reactions, possibly without impairing immunity
against infections or tumors that will be explored in the next
steps. Dynamic switching of M1 and M2 macrophages has a
key impact on the restoration of normal function in all tissues
after injury or infection.52−54 For example, it has been shown
that metabolic diseases such as type 2 diabetes can be
exacerbated by M1 macrophages but ameliorated by M2
ones.46,55 IL-4 is one of the main anti-inﬂammatory cytokines
that can suppress the secretion of proinﬂammatory cytokines
and induce M2 polarization for the therapy of various
inﬂammatory disease models.13,15,16,47 Nevertheless, IL-4-
mediated therapy is hampered due to the short half-life of
this biomolecule and rapid degradation, and its compensation
requires a high dose of the cytokine and toleration of inevitable
systemic side eﬀects.10 This drawback was recently circum-
vented by viral transduction of the IL-4 gene.56 Since the
delivery of exogenous genes to human needs to meet certain
safety regulations and cannot speciﬁcally aﬀect the macro-
phages, our present work aimed for the ﬁrst time to
demonstrate an eﬃcient targeted delivery system for IL-4
toward CD44-positive macrophages for the future translation
of exogenous IL-4 into clinic with minimal concern as
compared to other suggested approaches.
3. CONCLUSIONS
In this study, the polarization of macrophages toward anti-
inﬂammatory M2 phenotypes was reported by IL-4-encapsu-
lated HA carriers. The HA particles were successfully
synthesized from various MWs of the HA polymer using a
simple method, and the characterization and toxicity studies
showed their high safety and desirable properties for drug
delivery. Further investigation demonstrated that HA particles
prepared from HMW polymers signiﬁcantly increase the anti-
inﬂammatory markers of the macrophages, whereas the
particles fabricated from LMW and MMW polymers had
negligible eﬀect on the induction of anti-inﬂammatory
cytokines. Therefore, HMW polymer was used for IL-4
loading and M2 diﬀerentiation studies. The particles were
able to eﬃciently interact by J774A.1 macrophages that express
the CD44 receptor. Importantly, in vitro treatment of the M1
macrophages with IL-4-loaded HA particles enhanced the Arg-
1/iNOS gene expression levels. Moreover, the CD206 and
CD163 expressions were upregulated as the known markers of
M2a macrophages. The results indicate that macrophages were
successfully skewing their phenotype from M1 to M2 using the
anti-inﬂammatory cytokine-loaded HA particle, suggesting its
high potential for the targeted treatment of various auto-
immune and inﬂammation-associated diseases.
4. EXPERIMENTAL METHODS
4.1. Materials. Dioctyl sulfosuccinate sodium salt (AOT),
2,2,4-trimethylpentane (isooctane, anhydrous), divinyl sulfone
(DVS), 1-heptanol (1-HP), acetone dichloroﬂuorescin-diac-
etate, N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hy-
drochloride (EDC), N-hydroxysuccinimide (NHS), and lip-
opolysaccharide (LPS) were purchased from Sigma-Aldrich
Chemical Co (Germany). CellTiter-Glo Luminescence Cell
Viability assay kit was obtained from Promega Corporation.
HA (sodium salt, 10−20, 151−300, and 1.01−1.8 kDa) was
purchased from Lifcore Biomedical Co. Alexa Fluor 488
conjugated rabbit anti-CD163/M130 polyclonal antibody was
purchased from Bioss Antibodies. Alexa Fluor 488-antimouse
CD206 and CD44 antibodies were obtained from BioLegend.
J774A.1-adherent murine macrophage cell line was obtained
from the American Type Culture Collection. Fetal bovine
serum (FBS) was from HyClone, Dulbecco’s modiﬁed Eagle
medium (DMEM) was from Cellgro, and penicillin/
streptomycin antibiotics were from Gibco Invitrogen. Speciﬁc
primers of Arg-1 and iNOS2 were purchased from Euroﬁns
MWG Operon. Recombinant Mouse IL-4 and enzyme-linked
immunosorbent assay (ELISA) kits for IL-10, TNF-α, and IL-4
were obtained from R&D Systems.
4.2. Synthesis of HA Microparticles. HA microparticles
were synthesized using the reverse micelle cross-linking
technique and the formation of a water-in-oil inverse
microemulsion droplets, as shown in Figure 1. The aqueous
phase was prepared by dissolving HA in NaOH (0.2 M) at a
concentration of 4 mg/mL. The organic phase was isooctane
containing 0.2 M of AOT and 0.04 M of 1-HP in isooctane. To
prepare the droplets, 0.25 mL of HA solution was added to 7.5
mL of isooctane containing 0.2 M of AOT and 0.04 M of 1-HP
under vigorous agitation until a clear solution was obtained.
Next, 4 μL of DVS cross-linker was added under vortexing, and
the reaction was allowed to complete for 1 h under stirring at
room temperature. Particles were precipitated using 100 mL of
acetone and then collected by centrifugation at 10 000 rpm for
10 min. Next, the particles were washed three times with
acetone and water mixture (1:1 v/v) and once with water
before using them in other experiments.
4.3. Characterization of the HA Particles. The sizes
(hydrodynamic diameter) and ζ-potentials of the HA particles
prepared by low, middle, and high molecular weight HAs were
measured using a Zetasizer Nano ZS instrument (Malvern
Instruments Ltd, U.K.). For this purpose, particles were
dispersed in 0.01 M of KNO3 solution in water and then
sonicated for 20 min to obtain highly dispersed particles.
The changes in the sizes of particles synthesized with LMW,
MMW, and HMW HAs were determined in diﬀerent pH
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values, ranging from 2 to 11, using a particle size analyzer. The
pH was adjusted with 1 M of HCl and 1 M of NaOH. The
measurements were performed in a solution of NaCl (100
mM) to ensure ﬁxed ionic strength for all measurements. In
addition, the surface characterization of the particles was
investigated by ζ-potential measurements at various pH values
in 0.01 M of KCl solution. Before the study, the HA particles
were passed through paper ﬁlters with pore size >2 μm to
ensure there is no larger HA particle for proper measurement
within the operational size limit of the DLS instrument. Each
sample was measured in triplicate, and average size and ζ-
potential were reported with standard deviation (SD).
Attenuated total reﬂectance-Fourier transform infrared
(ATR-FTIR) study was carried out to investigate the chemical
compositions of the HA particles. A PerkinElmer Spectrum
100 FTIR spectrometer equipped with a diamond crystal ATR
accessory was used for this purpose. The particles were freeze-
dried, and the powder was used for spectra recording in the
wavenumber region of 4000−1000 cm−1 with a resolution of 4
cm−1.
The thermal stability of the particles was determined by
thermogravimetric analysis (TGA) using Q500 Thermogravi-
metric Analyzers. The thermogravimetry measurements were
carried out under continuous N2 ﬂow (200 mL/min). The
heating rate was 10 °C/min to reach up to 950 °C.
SEM (FEI Quanta 200) study was also performed to
monitor the morphology of diﬀerent particles. Samples were
separately embedded on the SEM holder covered by a double-
sided carbon adhesive tape. The particles were then dried at
room temperature overnight and then sputtered by Pt in a high
vacuum evaporator before imaging.
4.4. Cell Lines and Culturing Condition. Peripheral
blood mononuclear cells (PBMC), KG-1 macrophage cells,
and J774A.1 macrophages were used for diﬀerent studies of the
present work. Iscove’s modiﬁed Dulbecco’s medium and
Dulbecco’s modiﬁed Eagle’s medium (DMEM) were used
for the KG-1 and J774A.1, respectively. The media used in this
study were supplemented with 10% (v/v) fetal FBS, 1% L-
glutamine, penicillin (100 IU/mL), 1% nonessential amino
acids, and streptomycin (100 mg/mL) (all from HyClone).
The cells were obtained from American Type Culture
Collection and cultured in 75 cm2 culture ﬂasks (Corning
Inc. Life Sciences). Cells were cultured in a standard gas
incubator with the conditions of 95% humidity, 5% CO2, and
37 °C. Conﬂuency of 80% was considered for the subculturing
of the cells. Phosphate buﬀer solution−ethylenediaminetetra-
acetic acid (PBS−EDTA) solution was used for cell detach-
ment prior to passaging, as well as prior to each experiment.
4.5. Cellular Cytotoxicity. The ATP activity of the cells
was investigated for cytocompatibility assessment because it is
representative of mitochondrial function. For this purpose, 100
μL of the cell suspension (2 × 105 cells/mL) was seeded in 96-
well plates and left in an incubator at 37 °C overnight. Next,
the cell media were removed and 100 μL of the HA particles
with the concentrations of 25, 50, 100, 200, 400, and 600 μg/
mL were added into the wells containing cells. After 24 and 48
h of incubating cells with the particles, 100 μL of the reagent
assay (CellTiter-Glo Luminescent Cell Viability Assay,
Promega) was added to each well. The 96-well plates were
shaken for 2 min at 450 rpm and left at room temperature for
15 min before measuring the luminescence of the wells. Hanks’
balanced salt solution (HBSS) buﬀer solution was used as the
negative control and treated similarly as described above and
considered as 100% viability. The results presented are the
average of at least three independent measurements.
4.6. Hemocompatibility Assay. Heparinized fresh human
blood samples were used for the isolation of red blood cells
(RBCs). First, 5 mL of blood was mixed with 10 mL of D-PBS
and centrifuged at 2500 rpm for 6 min. This step was repeated
ﬁve times, and the ﬁnal RBC pellet was used to prepare 5%
hematocrit suspension by mixing 1 mL of the packed RBC
with 19 mL of D-PBS. The hemolytic eﬀect of the HA particles
was investigated by adding 200 μL of the 5% hematocrit to 800
μL of the diﬀerent HA particle suspensions in D-PBS to reach
the ﬁnal concentrations of 100, 200, and 400 μg/mL. Each of
the samples was vortexed for 5 s and subsequently incubated at
room temperature for 1, 6, and 24 h. In each time point, the
samples were gently vortexed for 5 s and centrifuged at 6000
rpm for 3 min. A 100 μL amount of the supernatant was
withdrawn and added to 96-well plates (Corning Inc. Life
Sciences) for the quantiﬁcation of the lysed hemoglobin at 577
nm. D-PBS and Milli-Q water were used as negative and
positive controls, respectively. The results represent the
average of, at least, three independent experiments.
4.7. Arg-1 Activity and Cytokine Measurement. To
study the impact of polymer MW on the polarization of the
macrophages, pure particles were exposed to J774A.1 macro-
phages in the presence or absence of HA particles in diﬀerent
conditions, including (1) in the resting state of macrophages,
that is, adding HA particles in the absence of activating agents;
(2) with 100 ng/mL of γ-irradiated lipopolysaccharide (LPS)
derived from Escherichia coli (Sigma-Aldrich); and (3) with 10
ng/mL interferon-γ (IFN-γ) and 100 ng/mL γ-irradiated LPS.
For all in vitro studies, J774A.1 macrophages were plated at a
density of 2.8 × 105 cells/mL in a 12-well plate (1.2 mL/well)
and allowed to adhere overnight before use. HA particles were
used at the concentration of 100 μg/mL for these studies.
Flow cytometry experiment was performed to quantitatively
assess the expression of Arg-1 in the cells as an indicator of M2
polarization in macrophages. For this experiment, resting
macrophages were treated as described above for 24 h. The
well plates were then washed with HBSS−(4-(2-hydroxyeth-
yl)-1-piperazineethanesulfonic acid) (HEPES) (pH 7.4), and
cells were harvested using PBS−EDTA solution. Thereafter,
detached cells were diluted with 5 mL of HBSS−(4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid) (HEPES) buf-
fer (pH 7.4) and transferred into 15 mL Falcon tubes to
separate cells through centrifugation at 1200 rpm for 4 min.
Samples were then dispersed in 0.5 mL of 4% paraformalde-
hyde at room temperature for 10 min under intermittent
agitation to maintain a single cell suspension during the
ﬁxation process. Cells were centrifuged and washed two times
with PBS (pH 7.4) before resuspending in 200 μL of
permeabilization buﬀer. Next, 10 μL of ﬂuorescein conjugated
Arg-1 antibody (R&D Systems) was added and cells incubated
for 30 min at room temperature in the dark. The cells were
washed once with permeabilization buﬀer and transferred into
FACS tubes after resuspending in 500 μL of PBS (pH 7.4) for
ﬂow cytometric analysis with a laser excitation wavelength of
488 nm.
TNF-α and IL-10 secreted by macrophages under diﬀerent
treatments were determined by the measurement of the
proteins in the supernatant of the cell culture using an enzyme-
linked immunosorbent assay (ELISA) kit (R&D Systems)
according to the manufacturer’s instructions. The amount of
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IL-4 loaded into the particles was measured using the ELISA
method.10
4.8. Cellular Interaction of the HA Particles with
J774A.1 Macrophages. The cellular interaction of the HMW
particles of HA polymer with J774A.1 macrophage cells was
performed using the Alexa Fluor 488 conjugated particles.
EDC−NHS-mediated labeling of the HA particles was carried
out through the previous reports of our group for other
nanocarriers.57 Flow cytometry experiment was conducted to
determine the percentage of cells associated with the HA
particles. In a 6-well plate, a density of 5 × 105 cells/well was
prepared in 3.5 mL of the culturing medium. After overnight
preincubation at 37 °C and 5% CO2, the cells were washed
once with HBSS−HEPES buﬀer (pH 7.4) and incubated with
3.5 mL of ﬂuorescently labeled particles (100 μg/mL) for 15,
30, 60, 90, and 120 min. Washing was then performed by
HBSS−HEPES (pH 7.4) to remove free particles. The cells
were detached by 300 μL of PBS−EDTA and centrifuged
within 5 mL of HBSS−HEPES buﬀer (pH 7.4) at 1200 rpm
for 4 min. The cells were resuspended in 700 μL of the HBSS−
HEPES (pH 7.4) and kept in ice for ﬂow cytometry analysis of
the samples with a laser excitation wavelength of 488 nm.
4.9. IL-4 Loading into HA Particles. To load the IL-4
cytokine within the HMW HA particles, 0.25 mL of HA
solution (4 mg/mL) was transferred into a tube containing 500
ng of the IL-4 in 50 μL. After a gentle vortexing, the mixture
was added dropwise into 7.5 mL of isooctane containing 0.2 M
of AOT and 0.04 M of 1-HP under vigorous agitation until a
clear solution was obtained. Next, 4 μL of DVS cross-linker
was added under vortexing, and the reaction was allowed to
complete for 1 h under stirring at room temperature. The
procedure was continued similar to the synthesis process
without the cytokine. Loaded amount of IL-4 into HA particles
was measured through the collection of the supernatant and its
analysis by IL-4 ELISA kits right after particle formation.
4.10. Analyses of CD44, CD206, and CD163 Ex-
pressions on Macrophage. J774A.1 macrophages were
plated in six-well plates with a density of 4 × 105 cells/well,
cultured at 37 °C and 5% CO2 overnight. For the evaluation of
CD44 expression, unpolarized J774A.1 macrophage cells were
treated with bovine albumin serum (BSA; 3% w/v) for 30 min
before 1 h staining with antimouse CD44 antibody at room
temperature. After washing thrice with PBS (pH 7.4) and
ﬁxation with the paraformaldehyde (4%) for 2 h, the cells were
imaged by confocal microscopy and analyzed by ﬂow
cytometry for the detection of CD44 surface proteins.
Nonstained unpolarized J774A.1 macrophage cells were used
as control.
For the determination of CD206 and CD163 expressions,
the cells were ﬁrst polarized to M1 phenotype by incubating
with IFN-γ (100 ng/mL) and LPS (100 ng/mL) for 16 h.
They were then treated with IL-4-loaded HA particles (1.2 mL
of 100 μg/mL) and unloaded particles for 48 h. After washing
and ﬁxation in 4% paraformaldehyde, 3% w/v BSA was used
for 30 min at room temperature to block nonspeciﬁc bindings.
The cells were then stained with Alexa Fluor 488-antimouse
CD206 and CD163 antibodies for 1 h.
4.11. In Vitro Polarization Studies. The eﬀect of the IL-
4-loaded HA particles on the induction of macrophage
switching from M1 to M2 phenotype was assessed by
measuring the change in the expression level of inducible
nitric oxide synthase 2 (iNOS2) as M1 marker and Arg-1 as
M2 marker in J774A.1 macrophages. After the exposure of the
cells (3 × 105 cells/well) to LPS (100 ng/mL) and IFN-γ (100
ng/mL) in 6-well plates for 16 h, the cells were exposed to the
IL-4-encapsulated particles (1.2 mL of 100 μg/mL) and free
particles for 24 h. Next, the cells were divided into two groups:
(1) washing with PBS and quantiﬁcation of the expression of
iNOS2 and Arg-1 using qPCR (called 24 h samples in the
Results and Discussion section) and (2) harvesting the cells
and culturing them in the cell culturing medium for 24 h more
before qPCR study (called 24 h samples in the Results and
Discussion section). The ratio of Arg-1 to iNOS2 was
considered as indicative of M1 to M2 polarization eﬃciency.
4.12. Data Analysis. Data were expressed as mean ±
standard deviation (SD). Statistical signiﬁcance was deter-
mined by one-way analysis of variance tests to compare
statistical signiﬁcance at a 5% probability level. A probability
(p) of less than 0.05 was considered statistically signiﬁcant.
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support from the Sigrid Juseĺius Foundation (Decision no.
4704580), the Helsinki Institute of Life Science, and the
Academy of Finland (Decision no. 1317042).
■ REFERENCES
(1) Boechat, A. L.; De Oliveira, C. P.; Tarrago, A. M.; Da Costa, A.
G.; Malheiro, A.; Guterres, S. S.; Pohlmann, A. R. Methotrexate-
Loaded Lipid-Core Nanocapsules Are Highly Effective in the Control
of Inflammation in Synovial Cells and a Chronic Arthritis Model. Int.
J. Nanomed. 2015, 10, 6603−6614.
(2) Kuo, R.; Saito, E.; Miller, S. D.; Shea, L. D. Peptide-Conjugated
Nanoparticles Reduce Positive Co-Stimulatory Expression and T Cell
Activity to Induce Tolerance. Mol. Ther. 2017, 25, 1676−1685.
(3) Dolati, S.; Babaloo, Z.; Jadidi-Niaragh, F.; Ayromlou, H.;
Sadreddini, S.; Yousefi, M. Multiple Sclerosis: Therapeutic
Applications of Advancing Drug Delivery Systems. Biomed. Pharmac-
other. 2017, 86, 343−353.
(4) Dolati, S.; Sadreddini, S.; Rostamzadeh, D.; Ahmadi, M.; Jadidi-
Niaragh, F.; Yousefi, M. Utilization of Nanoparticle Technology in
Rheumatoid Arthritis Treatment. Biomed. Pharmacother. 2016, 80,
30−41.
ACS Omega Article
DOI: 10.1021/acsomega.8b03182
ACS Omega 2018, 3, 18444−18455
18453
(5) Pujol-Autonell, I.; Mansilla, M. J.; Rodriguez-Fernandez, S.;
Cano-Sarabia, M.; Navarro-Barriuso, J.; Ampudia, R. M.; Rius, A.;
Garcia-Jimeno, S.; Perna-Barrull, D.; Caceres, E. M.; et al. Liposome-
Based Immunotherapy against Autoimmune Diseases: Therapeutic
Effect on Multiple Sclerosis. Nanomedicine 2017, 12, 1231−1242.
(6) Shah, M.; Edman, M. C.; Janga, S. R.; Shi, P.; Dhandhukia, J.;
Liu, S.; Louie, S. G.; Rodgers, K.; MacKay, J. A.; Hamm-Alvarez, S. F.
A Rapamycin-Binding Protein Polymer Nanoparticle Shows Potent
Therapeutic Activity in Suppressing Autoimmune Dacryoadenitis in a
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